Article

BEST PRACTICES IN: Oral Cancer Therapies: Important Prescribing Considerations

Sponsored by Novartis Pharmaceuticals

 

A supplement to The Journal of Community and Supportive Oncology. This supplement was sponsored by Novartis Pharmaceuticals.

To view the supplement, click the image to the right

Next Article:

   Comments ()

Recommended for You

News & Commentary

Quizzes from MD-IQ

Research Summaries from ClinicalEdge